-
1
-
-
77952798832
-
Epigenetic Signatures in Breast Cancer: Clinical Perspective
-
Parrella P, (2010) Epigenetic Signatures in Breast Cancer: Clinical Perspective. Breast Care (Basel) 5: 66-73.
-
(2010)
Breast Care (Basel)
, vol.5
, pp. 66-73
-
-
Parrella, P.1
-
2
-
-
0036274359
-
The fundamental role of epigenetic events in cancer
-
Jones PA, Baylin SB, (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3: 415-428.
-
(2002)
Nat Rev Genet
, vol.3
, pp. 415-428
-
-
Jones, P.A.1
Baylin, S.B.2
-
3
-
-
0345357773
-
Gene silencing in cancer in association with promoter hypermethylation
-
Herman JG, Baylin SB, (2003) Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349: 2042-2054.
-
(2003)
N Engl J Med
, vol.349
, pp. 2042-2054
-
-
Herman, J.G.1
Baylin, S.B.2
-
4
-
-
70350068690
-
DNA methylation and cancer diagnosis: new methods and applications
-
Dehan P, Kustermans G, Guenin S, Horion J, Boniver J, et al. (2009) DNA methylation and cancer diagnosis: new methods and applications. Expert Rev Mol Diagn 9: 651-657.
-
(2009)
Expert Rev Mol Diagn
, vol.9
, pp. 651-657
-
-
Dehan, P.1
Kustermans, G.2
Guenin, S.3
Horion, J.4
Boniver, J.5
-
5
-
-
77951039961
-
DNA methylation based biomarkers in non-invasive cancer screening
-
Shivapurkar N, Gazdar AF, (2010) DNA methylation based biomarkers in non-invasive cancer screening. Curr Mol Med 10: 123-132.
-
(2010)
Curr Mol Med
, vol.10
, pp. 123-132
-
-
Shivapurkar, N.1
Gazdar, A.F.2
-
7
-
-
23044506681
-
The ubiquitin-proteasome pathway and its role in cancer
-
Mani A, Gelmann EP, (2005) The ubiquitin-proteasome pathway and its role in cancer. J Clin Oncol 23: 4776-4789.
-
(2005)
J Clin Oncol
, vol.23
, pp. 4776-4789
-
-
Mani, A.1
Gelmann, E.P.2
-
8
-
-
0038743111
-
The role of the ubiquitination-proteasome pathway in breast cancer: applying drugs that affect the ubiquitin-proteasome pathway to the therapy of breast cancer
-
Orlowski RZ, Dees EC, (2003) The role of the ubiquitination-proteasome pathway in breast cancer: applying drugs that affect the ubiquitin-proteasome pathway to the therapy of breast cancer. Breast Cancer Res 5: 1-7.
-
(2003)
Breast Cancer Res
, vol.5
, pp. 1-7
-
-
Orlowski, R.Z.1
Dees, E.C.2
-
9
-
-
0037131567
-
The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility
-
Liu Y, Fallon L, Lashuel HA, Liu Z, Lansbury PT Jr, (2002) The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility. Cell 111: 209-218.
-
(2002)
Cell
, vol.111
, pp. 209-218
-
-
Liu, Y.1
Fallon, L.2
Lashuel, H.A.3
Liu, Z.4
Lansbury Jr., P.T.5
-
10
-
-
10744224825
-
Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron
-
Osaka H, Wang YL, Takada K, Takizawa S, Setsuie R, et al. (2003) Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron. Hum Mol Genet 12: 1945-1958.
-
(2003)
Hum Mol Genet
, vol.12
, pp. 1945-1958
-
-
Osaka, H.1
Wang, Y.L.2
Takada, K.3
Takizawa, S.4
Setsuie, R.5
-
11
-
-
77953099661
-
The tumor suppressor UCHL1 forms a complex with p53/MDM2/ARF to promote p53 signaling and is frequently silenced in nasopharyngeal carcinoma
-
Li L, Tao Q, Jin H, van Hasselt A, Poon FF, et al. (2010) The tumor suppressor UCHL1 forms a complex with p53/MDM2/ARF to promote p53 signaling and is frequently silenced in nasopharyngeal carcinoma. Clin Cancer Res 16: 2949-2958.
-
(2010)
Clin Cancer Res
, vol.16
, pp. 2949-2958
-
-
Li, L.1
Tao, Q.2
Jin, H.3
van Hasselt, A.4
Poon, F.F.5
-
12
-
-
79551484520
-
A survey of methylated candidate tumor suppressor genes in nasopharyngeal carcinoma
-
Loyo M, Brait M, Kim MS, Ostrow KL, Jie CC, et al. (2011) A survey of methylated candidate tumor suppressor genes in nasopharyngeal carcinoma. Int J Cancer 128: 1393-1403.
-
(2011)
Int J Cancer
, vol.128
, pp. 1393-1403
-
-
Loyo, M.1
Brait, M.2
Kim, M.S.3
Ostrow, K.L.4
Jie, C.C.5
-
13
-
-
21144442201
-
PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma
-
Mandelker DL, Yamashita K, Tokumaru Y, Mimori K, Howard DL, et al. (2005) PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma. Cancer Res 65: 4963-4968.
-
(2005)
Cancer Res
, vol.65
, pp. 4963-4968
-
-
Mandelker, D.L.1
Yamashita, K.2
Tokumaru, Y.3
Mimori, K.4
Howard, D.L.5
-
14
-
-
68149163598
-
The presence of aberrant DNA methylation in noncancerous esophageal mucosae in association with smoking history: a target for risk diagnosis and prevention of esophageal cancers
-
Oka D, Yamashita S, Tomioka T, Nakanishi Y, Kato H, et al. (2009) The presence of aberrant DNA methylation in noncancerous esophageal mucosae in association with smoking history: a target for risk diagnosis and prevention of esophageal cancers. Cancer 115: 3412-3426.
-
(2009)
Cancer
, vol.115
, pp. 3412-3426
-
-
Oka, D.1
Yamashita, S.2
Tomioka, T.3
Nakanishi, Y.4
Kato, H.5
-
15
-
-
49649107454
-
Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors
-
Yu J, Tao Q, Cheung KF, Jin H, Poon FF, et al. (2008) Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors. Hepatology 48: 508-518.
-
(2008)
Hepatology
, vol.48
, pp. 508-518
-
-
Yu, J.1
Tao, Q.2
Cheung, K.F.3
Jin, H.4
Poon, F.F.5
-
16
-
-
71149090166
-
Epigenetic control of the ubiquitin carboxyl terminal hydrolase 1 in renal cell carcinoma
-
Seliger B, Handke D, Schabel E, Bukur J, Lichtenfels R, et al. (2009) Epigenetic control of the ubiquitin carboxyl terminal hydrolase 1 in renal cell carcinoma. J Transl Med 7: 90.
-
(2009)
J Transl Med
, vol.7
, pp. 90
-
-
Seliger, B.1
Handke, D.2
Schabel, E.3
Bukur, J.4
Lichtenfels, R.5
-
17
-
-
33747514481
-
Silencing of the UCHL1 gene in human colorectal and ovarian cancers
-
Okochi-Takada E, Nakazawa K, Wakabayashi M, Mori A, Ichimura S, et al. (2006) Silencing of the UCHL1 gene in human colorectal and ovarian cancers. Int J Cancer 119: 1338-1344.
-
(2006)
Int J Cancer
, vol.119
, pp. 1338-1344
-
-
Okochi-Takada, E.1
Nakazawa, K.2
Wakabayashi, M.3
Mori, A.4
Ichimura, S.5
-
19
-
-
0026326653
-
The gene for human neurone specific ubiquitin C-terminal hydrolase (UCHL1, PGP9.5) maps to chromosome 4p14
-
Edwards YH, Fox MF, Povey S, Hinks LJ, Thompson RJ, et al. (1991) The gene for human neurone specific ubiquitin C-terminal hydrolase (UCHL1, PGP9.5) maps to chromosome 4p14. Ann Hum Genet 55: 273-278.
-
(1991)
Ann Hum Genet
, vol.55
, pp. 273-278
-
-
Edwards, Y.H.1
Fox, M.F.2
Povey, S.3
Hinks, L.J.4
Thompson, R.J.5
-
20
-
-
34249845272
-
Reversible monoubiquitination regulates the Parkinson disease-associated ubiquitin hydrolase UCH-L1
-
Meray RK, Lansbury PT Jr, (2007) Reversible monoubiquitination regulates the Parkinson disease-associated ubiquitin hydrolase UCH-L1. J Biol Chem 282: 10567-10575.
-
(2007)
J Biol Chem
, vol.282
, pp. 10567-10575
-
-
Meray, R.K.1
Lansbury Jr., P.T.2
-
21
-
-
33744510119
-
High expression of ubiquitin carboxy-terminal hydrolase-L1 and -L3 mRNA predicts early recurrence in patients with invasive breast cancer
-
Miyoshi Y, Nakayama S, Torikoshi Y, Tanaka S, Ishihara H, et al. (2006) High expression of ubiquitin carboxy-terminal hydrolase-L1 and-L3 mRNA predicts early recurrence in patients with invasive breast cancer. Cancer Sci 97: 523-529.
-
(2006)
Cancer Sci
, vol.97
, pp. 523-529
-
-
Miyoshi, Y.1
Nakayama, S.2
Torikoshi, Y.3
Tanaka, S.4
Ishihara, H.5
-
22
-
-
58149189304
-
Over-expression of ubiquitin carboxy terminal hydrolase-L1 induces apoptosis in breast cancer cells
-
Wang WJ, Li QQ, Xu JD, Cao XX, Li HX, et al. (2008) Over-expression of ubiquitin carboxy terminal hydrolase-L1 induces apoptosis in breast cancer cells. Int J Oncol 33: 1037-1045.
-
(2008)
Int J Oncol
, vol.33
, pp. 1037-1045
-
-
Wang, W.J.1
Li, Q.Q.2
Xu, J.D.3
Cao, X.X.4
Li, H.X.5
-
23
-
-
77955549420
-
Genomic screening for genes upregulated by demethylation revealed novel targets of epigenetic silencing in breast cancer
-
Fujikane T, Nishikawa N, Toyota M, Suzuki H, Nojima M, et al. (2010) Genomic screening for genes upregulated by demethylation revealed novel targets of epigenetic silencing in breast cancer. Breast Cancer Res Treat 122: 699-710.
-
(2010)
Breast Cancer Res Treat
, vol.122
, pp. 699-710
-
-
Fujikane, T.1
Nishikawa, N.2
Toyota, M.3
Suzuki, H.4
Nojima, M.5
-
24
-
-
75749132016
-
USP10 regulates p53 localization and stability by deubiquitinating p53
-
Yuan J, Luo K, Zhang L, Cheville JC, Lou Z, (2010) USP10 regulates p53 localization and stability by deubiquitinating p53. Cell 140: 384-396.
-
(2010)
Cell
, vol.140
, pp. 384-396
-
-
Yuan, J.1
Luo, K.2
Zhang, L.3
Cheville, J.C.4
Lou, Z.5
-
25
-
-
0034657294
-
Cytoplasmic sequestration and functional repression of p53 in the mammary epithelium is reversed by hormonal treatment
-
Kuperwasser C, Pinkas J, Hurlbut GD, Naber SP, Jerry DJ, (2000) Cytoplasmic sequestration and functional repression of p53 in the mammary epithelium is reversed by hormonal treatment. Cancer Res 60: 2723-2729.
-
(2000)
Cancer Res
, vol.60
, pp. 2723-2729
-
-
Kuperwasser, C.1
Pinkas, J.2
Hurlbut, G.D.3
Naber, S.P.4
Jerry, D.J.5
-
26
-
-
0026694826
-
Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion
-
Moll UM, Riou G, Levine AJ, (1992) Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc Natl Acad Sci U S A 89: 7262-7266.
-
(1992)
Proc Natl Acad Sci U S A
, vol.89
, pp. 7262-7266
-
-
Moll, U.M.1
Riou, G.2
Levine, A.J.3
-
27
-
-
55749091975
-
PGP9.5 methylation as a marker for metastatic colorectal cancer
-
Mizukami H, Shirahata A, Goto T, Sakata M, Saito M, et al. (2008) PGP9.5 methylation as a marker for metastatic colorectal cancer. Anticancer Res 28: 2697-2700.
-
(2008)
Anticancer Res
, vol.28
, pp. 2697-2700
-
-
Mizukami, H.1
Shirahata, A.2
Goto, T.3
Sakata, M.4
Saito, M.5
-
28
-
-
54249101906
-
Aberrant promoter methylation of multiple genes during pathogenesis of bladder cancer
-
Brait M, Begum S, Carvalho AL, Dasgupta S, Vettore AL, et al. (2008) Aberrant promoter methylation of multiple genes during pathogenesis of bladder cancer. Cancer Epidemiol Biomarkers Prev 17: 2786-2794.
-
(2008)
Cancer Epidemiol Biomarkers Prev
, vol.17
, pp. 2786-2794
-
-
Brait, M.1
Begum, S.2
Carvalho, A.L.3
Dasgupta, S.4
Vettore, A.L.5
-
29
-
-
67449127092
-
CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis
-
Wang Y, Li J, Cui Y, Li T, Ng KM, et al. (2009) CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis. Cancer Res 69: 5194-5201.
-
(2009)
Cancer Res
, vol.69
, pp. 5194-5201
-
-
Wang, Y.1
Li, J.2
Cui, Y.3
Li, T.4
Ng, K.M.5
-
30
-
-
77955728660
-
KRAB zinc finger protein ZNF382 is a proapoptotic tumor suppressor that represses multiple oncogenes and is commonly silenced in multiple carcinomas
-
Cheng Y, Geng H, Cheng SH, Liang P, Bai Y, et al. (2010) KRAB zinc finger protein ZNF382 is a proapoptotic tumor suppressor that represses multiple oncogenes and is commonly silenced in multiple carcinomas. Cancer Res 70: 6516-6526.
-
(2010)
Cancer Res
, vol.70
, pp. 6516-6526
-
-
Cheng, Y.1
Geng, H.2
Cheng, S.H.3
Liang, P.4
Bai, Y.5
-
31
-
-
52049115449
-
OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation
-
Cui Y, Ying Y, van Hasselt A, Ng KM, Yu J, et al. (2008) OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation. PLoS One 3: e2990.
-
(2008)
PLoS One
, vol.3
-
-
Cui, Y.1
Ying, Y.2
van Hasselt, A.3
Ng, K.M.4
Yu, J.5
-
32
-
-
33846941189
-
The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation
-
Seng TJ, Low JS, Li H, Cui Y, Goh HK, et al. (2007) The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation. Oncogene 26: 934-944.
-
(2007)
Oncogene
, vol.26
, pp. 934-944
-
-
Seng, T.J.1
Low, J.S.2
Li, H.3
Cui, Y.4
Goh, H.K.5
-
33
-
-
77957143981
-
PLCD1 is a functional tumor suppressor inducing G(2)/M arrest and frequently methylated in breast cancer
-
Xiang T, Li L, Fan Y, Jiang Y, Ying Y, et al. (2010) PLCD1 is a functional tumor suppressor inducing G(2)/M arrest and frequently methylated in breast cancer. Cancer Biol Ther 10: 520-527.
-
(2010)
Cancer Biol Ther
, vol.10
, pp. 520-527
-
-
Xiang, T.1
Li, L.2
Fan, Y.3
Jiang, Y.4
Ying, Y.5
-
34
-
-
33244483580
-
Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation
-
Ying J, Li H, Seng TJ, Langford C, Srivastava G, et al. (2006) Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation. Oncogene 25: 1070-1080.
-
(2006)
Oncogene
, vol.25
, pp. 1070-1080
-
-
Ying, J.1
Li, H.2
Seng, T.J.3
Langford, C.4
Srivastava, G.5
-
35
-
-
2942737278
-
The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma
-
Qiu GH, Tan LK, Loh KS, Lim CY, Srivastava G, et al. (2004) The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma. Oncogene 23: 4793-4806.
-
(2004)
Oncogene
, vol.23
, pp. 4793-4806
-
-
Qiu, G.H.1
Tan, L.K.2
Loh, K.S.3
Lim, C.Y.4
Srivastava, G.5
-
36
-
-
28844433721
-
A simple and fast densitometric method for the analysis of tyrosine hydroxylase immunoreactivity in the substantia nigra pars compacta and in the ventral tegmental area
-
Xavier LL, Viola GG, Ferraz AC, Da Cunha C, Deonizio JM, et al. (2005) A simple and fast densitometric method for the analysis of tyrosine hydroxylase immunoreactivity in the substantia nigra pars compacta and in the ventral tegmental area. Brain Res Brain Res Protoc 16: 58-64.
-
(2005)
Brain Res Brain Res Protoc
, vol.16
, pp. 58-64
-
-
Xavier, L.L.1
Viola, G.G.2
Ferraz, A.C.3
da Cunha, C.4
Deonizio, J.M.5
-
37
-
-
0344980092
-
Methylation status of the Epstein-Barr virus major latent promoter C in iatrogenic B cell lymphoproliferative disease. Application of PCR-based analysis
-
Tao Q, Swinnen LJ, Yang J, Srivastava G, Robertson KD, et al. (1999) Methylation status of the Epstein-Barr virus major latent promoter C in iatrogenic B cell lymphoproliferative disease. Application of PCR-based analysis. Am J Pathol 155: 619-625.
-
(1999)
Am J Pathol
, vol.155
, pp. 619-625
-
-
Tao, Q.1
Swinnen, L.J.2
Yang, J.3
Srivastava, G.4
Robertson, K.D.5
-
38
-
-
0036712913
-
Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells
-
Tao Q, Huang H, Geiman TM, Lim CY, Fu L, et al. (2002) Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells. Hum Mol Genet 11: 2091-2102.
-
(2002)
Hum Mol Genet
, vol.11
, pp. 2091-2102
-
-
Tao, Q.1
Huang, H.2
Geiman, T.M.3
Lim, C.Y.4
Fu, L.5
-
39
-
-
67650070519
-
Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer
-
Hu XT, Zhang FB, Fan YC, Shu XS, Wong AH, et al. (2009) Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer. Oncogene 28: 2466-2475.
-
(2009)
Oncogene
, vol.28
, pp. 2466-2475
-
-
Hu, X.T.1
Zhang, F.B.2
Fan, Y.C.3
Shu, X.S.4
Wong, A.H.5
|